Intrepid announces public offering of shares

Intrepid Potash Inc., Denver, Colo., announced today that it has commenced an underwritten public offering of shares of its common stock. The net proceeds from this offering are expected to be used to partially repay indebtedness outstanding under Intrepid’s senior notes and for general corporate purposes. Intrepid intends to grant the underwriter a 30-day option to purchase additional shares of common stock at the public offering price.

Cantor Fitzgerald & Co. is acting as the sole book-running manager of this offering. The offering will be made only by means of a preliminary prospectus supplement and the accompanying base prospectus, copies of which may be obtained by contacting Cantor Fitzgerald & Co., Attention: Capital Markets, 499 Park Ave., 5th Floor, New York, New York 10022, or by telephone at 212.829.7122, or by e-mail at prospectus@cantor.com. An electronic copy of the preliminary prospectus supplement and accompanying base prospectus may also be obtained at no charge from the Securities and Exchange Commission’s website at www.sec.gov.

Cameron affiliate acquires Kronos assets

Ultra Yield Micronutrients Inc., an affiliate of Cameron Chemicals Inc., Virginia Beach, Va., has acquired the assets of Kronos Micronutrients LP “Kronos” Zinc Sulfate Production Facility located in Moxee, Wash. Richard Camp, the former owner of Kronos, will join the new company, as a consultant. All other staff at Kronos are expected to remain in place. All products produced at the Moxee facility will continue to be marketed under the logos and trademarks Kronos-33.3 percent Zinc Sulfate and Blu-Min Zinc Sulfate 35.5 percent.

Disclaimer of Warranty
All information has been obtained by Green Markets from sources believed to be reliable. However, because of the possibility of human or mechanical error by our sources, Green Markets or others, Green Markets does not guarantee the accuracy, adequacy, or completeness of any information and is not responsible for any errors or omissions or for the results obtained from the use of such information.

For additional details visit our Terms of Use.